Morphoceuticals is a biotechnology platform utilizing multi-omics, bioelectric profiling, and AI to manipulate the bioelectrome, which governs tissue repair and organ regeneration. The company aims to enable regeneration and repair of damaged tissues in patients suffering from traumatic injuries, degenerative diseases, and organ failure.
Funding
$13.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
JPMFounders
Product
Problem
Current treatments for traumatic injuries, degenerative diseases, and organ failure often fall short, leaving many patients with inadequately addressed conditions and limited regenerative capabilities. The body's innate ability to repair and regenerate damaged tissues is not fully utilized in these conventional approaches.
Solution
Morphoceuticals is developing a technology platform that leverages multi-omics, bioelectric profiling, and artificial intelligence to understand and manipulate the bioelectrome—the network of communication within the body that governs tissue repair and organ regeneration. By modulating ion channels and bioelectric signaling, Morphoceuticals aims to unlock the body's dormant regenerative potential. The company is building an atlas of the bioelectrome to identify and target specific bioelectric patterns that can be rewritten to promote tissue regeneration and repair. This approach has the potential to address conditions currently inadequately treated by existing modalities.
Target Audience
The primary target audience includes patients suffering from traumatic injuries, degenerative diseases, and organ failure, as well as clinicians and researchers in the field of regenerative medicine.
Features
- Multi-omics analysis to map the molecular landscape of tissue regeneration
- Bioelectric profiling to identify key electrical signals involved in tissue repair
- AI-driven technology to modulate ion channels and bioelectric signaling pathways
- Development of targeted therapies to rewrite bioelectric patterns for tissue regeneration
- Platform for creating an atlas of the bioelectrome to accelerate discovery